Abstract
We previously reported the antibacterial activity of CD437, a known antitumor compound. It proved to be a potent antimicrobial agent effective against both growing and persister cells of methicillin-resistant Staphylococcus aureus (MRSA). Herein, we report the synthesis of a panel of analogs and their effect on both MRSA and cancer cells. The hydrophobic group of the parent compound was varied in steric bulk, and lipid-mimicking analogs were tested. Biological assessment confirmed that the adamantane moiety is the most effective substitution for antibacterial activity, and some preferential action in cancer over MRSA was achieved.
| Original language | English |
|---|---|
| Pages (from-to) | 393-397 |
| Number of pages | 5 |
| Journal | ACS Medicinal Chemistry Letters |
| Volume | 11 |
| Issue number | 3 |
| DOIs | |
| State | Published - 12 Mar 2020 |
Bibliographical note
Publisher Copyright:© 2019 American Chemical Society.
Keywords
- CD437
- Methicillin resistant Staphylococcus aureus
- cancer
- persister
- retinoid